Becker's ASC

Orthopedic Systems Developed for the ASC: Insights Into DePuy Synthes Select’s Innovative Business Model

DePuy Synthes has a well established reputation in the inpatient and hospital outpatient department setting. Now, the company is developing a new focus on freestanding ambulatory surgery centers: ...
IndustryWeek

2015 IW Best Plants Winner: At DePuy Synthes, Customer Focus Keeps Continuous Improvement at the Forefront

DePuy Synthes employees perform wax injection assembly for foundry casting. On a recent Tuesday in Raynham, Mass., Jerry, a retired mechanical engineer, stood in front of an assembled group and talked ...
Nasdaq

DePuy Synthes Launches the UNIUM™ System as a Next Generation Power Tools System for Trauma and Small Bone Procedures

PALM BEACH GARDENS, Fla., Nov. 22, 2021 /PRNewswire/ -- DePuy Synthes, The Orthopaedics Company of Johnson & Johnson*, has launched the UNIUM™ System as the newest addition to its Power Tools ...
Becker's ASC

Keeping up with the evolution of ASC instrumentation: Q&A with DePuy Synthes Advantage’s William Wilder

Technological advancements are largely responsible for the movement of higher acuity cases into the outpatient setting. William Wilder, director of DePuy Synthes Advantage Field Solutions, discusses ...
MobiHealthNews

DePuy Synthes, JointPoint collaborate on software for hip replacement surgery

DePuy Synthes has entered into an exclusive agreement with JointPoint Inc. to co-market a proprietary software platform that aims to help surgeons perform hip replacement surgeries. JointPoint's ...
Healio

DePuy Synthes launches 3-D simulation-assisted external fixation device

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. DePuy Synthes announced it has launched the Maxframe ...
NJ.com

Johnson & Johnson divests DePuy trauma business to clear way for Synthes deal

Indiana-based Biomet said it has made a binding offer to acquire the trauma business of Johnson & Johnson’s DePuy Orthopeadics subsidiary for approximately $280 million in cash. The deal is expected ...
FierceBiotech

DePuy Synthes rolls out 3D-printed facial implants from Materialise

The FDA cleared Materialise’s 3D-printed titanium implants for maxillofacial surgery. Johnson & Johnson’s DePuy Synthes unit will distribute the implants in the U.S., starting in mid-September. The ...
Business Wire

DePuy Synthes Addresses Clinical Demand to Reduce the Incidence of Implant Related Infections with Expert Tibial Nail PROtect

SOLOTHURN, Switzerland--(BUSINESS WIRE)--DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced the availability of Expert Tibial Nail PROtect, the only tibial nail with a ...
Seeking Alpha

DePuy Synthes Receives 510(k) FDA Clearance of the VELYS™ Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures

PALM BEACH GARDENS, Fla., June 7, 2024 /PRNewswire/ -- Today, Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson (JNJ)**, has received 510(k) FDA ...
FierceBiotech

J&J's DePuy Synthes unit slapped with FDA Class I recall for jaw-stabilizing device

DePuy's Craniomaxillofacial Distraction System lengthens and stabilizes bone in the lower jaw in patients with birth or post-traumatic defects, but the company uncovered a potentially deadly design ...